Vancouver, BC -- (SBWire) -- 05/07/2021 --The latest research on the Radiation Therapy Quality Assurance (QA) Phantoms market applies both qualitative and quantitative data analysis to present an overview of the future adjacencies around the Radiation Therapy Quality Assurance (QA) Phantoms industry for the forecast period, 2021-2028. The all-encompassing study pertaining to the market share, growth and size equip stakeholders, business owners, and field marketing personnel to obtain a unique knowledge about the current business environment to offer a competitive advantage over the giants
Quality check and assurance before delivering radiation treatment to a cancer patient is critical in order to maintain the radiation dose as prescribed by the doctor. Some major drivers fueling growth of the global market include enhancement of patient and machine quality assurance in radiation oncology, rising demand for tissue equivalent phantoms, and increasing number of cancer patients globally.
To get Free Sample PDF Copy of this Report @ https://www.emergenresearch.com/request-sample/505
The report discusses in detail the growth opportunities, challenges, market drivers and restraints, limitations, threats, and demands of the Radiation Therapy Quality Assurance (QA) Phantoms market.
Key players operating in the market are Computerized Imaging Reference Systems, Inc., Fluke Biomedical, IBA Dosimetry, Modus Medical Devices Inc., PTW Freiburg GmbH, Standard Imaging Inc., Sun Nuclear Corporation, The Phantom Laboratory Inc., Gammex Inc., and Gold Standard Phantoms.
The study further assesses the regional market as well as the international market to garner an insight into the scope of the market. The report also offers estimations and predictions about the market segment and sub-segments exhibiting promising growth in the forecast timeline. The report also provides deeper insights into the technological advancements, industrial landscape, and emerging product and technological developments in the Radiation Therapy Quality Assurance (QA) Phantoms market.
Segmental Analysis
The global Radiation Therapy Quality Assurance (QA) Phantoms market is broadly segmented on the basis of different product types, application range, end-use industries, key regions, and an intensely competitive landscape. This section of the report is solely targeted at readers looking to select the most appropriate and lucrative segments of the Radiation Therapy Quality Assurance (QA) Phantoms sector in a strategic manner. The segmental analysis also helps companies interested in this sector make optimal business decisions and achieve their desired goals.
For the purpose of this report, Emergen Research has segmented the global radiation therapy quality assurance (QA) phantoms market based on technology, therapy, application, and region as follows:
Technology Outlook (Revenue: USD Million; 2020–2028)
Linear Accelerators
Cobalt-60
High-Dose Radiation
Low-Dose Radiation
Therapy Outlook (Revenue: USD Million; 2020–2028)
Photon Beam Radiation Therapy
Advanced 3-D Conformal Radiation Therapy
Image Guided Radiation Therapy
Intensity-modulated radiation therapy
Volumetric Modulated Arc Therapy
Intraoperative Radiotherapy
Neutron Beam Therapy
Brachytherapy
Application Outlook (Revenue: USD Million; 2020–2028)
Prostate Cancer
Breast Cancer
Lung Cancer
Colorectal Cancer
Head and Neck Cancers
Skin Cancer
Other
This section of the report offers valuable insights into the geographical segmentation of the Radiation Therapy Quality Assurance (QA) Phantoms market, alongside estimating the current and future market valuations based on the demand-supply dynamics and pricing structure of the leading regional segments. Furthermore, the growth prospects of each segment and sub-segment have been meticulously described in the report.
Enquire for customization in Report @: https://www.emergenresearch.com/request-for-customization/505
The report classifies the global Radiation Therapy Quality Assurance (QA) Phantoms market into various regions, including:
North America (U.S., Canada)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Middle East & Africa (Saudi Arabia, the U.A.E., South Africa, Rest of MEA)
Report Highlights:
The report conducts a comparative assessment of the leading market players participating in the global Radiation Therapy Quality Assurance (QA) Phantoms market.
The report marks the notable developments that have recently taken place in the Radiation Therapy Quality Assurance (QA) Phantoms industry
It details on the strategic initiatives undertaken by the market competitors for business expansion.
It closely examines the micro- and macro-economic growth indicators, as well as the essential elements of the Radiation Therapy Quality Assurance (QA) Phantoms market value chain.
The repot further jots down the major growth prospects for the emerging market players in the leading regions of the market.
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Radiation Therapy Quality Assurance (QA) Phantoms Market Segmentation & Impact Analysis
4.1. Radiation Therapy Quality Assurance (QA) Phantoms Market Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing demand for tissue equivalent phantoms
4.2.2.2. Growing concern regarding patient safety
4.2.3. Market restraints analysis
4.2.3.1. High Cost of phantoms
4.2.3.2. Lack of skilled professionals
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter's Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Radiation Therapy Quality Assurance (QA) Phantoms Market Technology Insights & Trends, Revenue (USD Million)
5.1. Technology Dynamics & Market Share, 2019 & 2027
5.1.1. Linear Accelerators
5.1.2. Cobalt-60
5.1.3. High-Dose Radiation
5.1.4. Low-Dose Radiation
Chapter 6. Radiation Therapy Quality Assurance (QA) Phantoms Market Therapy Insights & Trends Revenue (USD Million)
6.1. Therapy Dynamics & Market Share, 2019 & 2027
6.1.1. Photon Beam Radiation Therapy
6.1.2. Advanced 3-D Conformal Radiation Therapy
6.1.3. Image Guided Radiation Therapy
6.1.4. Intensity-modulated radiation therapy
6.1.5. Volumetric Modulated Arc Therapy
6.1.6. Intraoperative Radiotherapy
6.1.7. Neutron Beam Therapy
6.1.8. Brachytherapy
Chapter 7. Radiation Therapy Quality Assurance (QA) Phantoms Market Application Insights & Trends Revenue (USD Million)
To Be Continued…!
Quick Buy---Radiation Therapy Quality Assurance (QA) Phantoms Market Research Report At: https://www.emergenresearch.com/select-license/505
Thank you for reading our report. Customization of this report is available as per the client's requirements. Please connect with us to know more about the report, and our team will ensure you get the report tailored according to your needs.
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Radiation Therapy Quality Assurance (QA) Phantoms Market Research Report Analysis 2021 – 2028 by Size, Share, Trends, Growth, Industry Analysis and Outlook
The global radiation therapy quality assurance (QA) phantoms market is expected to reach a market size of USD 36.4 Million by 2028 and register a steady CAGR over the forecast period, according to latest analysis by Emergen Research.